REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Duopharma (Singapore) Pte. Ltd. (Singapore)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Duopharma (Singapore) Pte. Ltd. Profile Updated: December 15, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Primary Business Activity: wholesale of medicinal and pharmaceutical products (western); Secondary Business Activity: wholesale of medicine and herbs (except western)

Legal Address
25 International Business Park, #03-24/25, German Centre, Singapore 609916
Singapore; Singapore; Postal Code: 609916

Contact Details: Purchase the Duopharma (Singapore) Pte. Ltd. report to view the information.

Basic Information
Total Employees:
Purchase the Duopharma (Singapore) Pte. Ltd. report to view the information.
Registered Capital:
Purchase the Duopharma (Singapore) Pte. Ltd. report to view the information.
Financial Auditors:
Purchase the Duopharma (Singapore) Pte. Ltd. report to view the information.
Incorporation Date:
June 16, 1982
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Duopharma (Singapore) Pte. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency SGD. Absolute financial data is included in the purchased report.
Net sales revenue
2.98%▲
Total operating revenue
2.98%▲
Net Profit/Loss for the Period
38.48%▲
Total Assets
-6.02%▼
Total Equity
13.41%▲
Net Profit Margin
2.94%▲
Return on Equity (ROE)
5.15%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo